Skip to main content
Back
Watch Compare

Silo Pharma, Inc.

Data quality: 100%
SILO
Nasdaq Manufacturing Chemicals
$0.42
▼ $0.03 (-5.88%)
Mkt Cap: 6.77 M
Price
$0.42
Mkt Cap
6.77 M
Day Range
$0.38 — $0.42
52-Week Range
$0.22 — $1.19
Volume
1,748,730
Open $0.38
50D / 200D Avg
$0.34
23.77% above
50D / 200D Avg
$0.51
17.79% below

Quick Summary

Key Takeaways

Negative free cash flow of -4.66 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-85.18%
Below sector avg (-53.41%)
ROIC-59.97%
Net Margin-5863.50%
Op. Margin-5936.95%

Safety

Debt / Equity
N/A
Current Ratio8.70
Interest Coverage-114.76

Valuation

PE (TTM)
-1.60
Below sector avg (-1.48)
P/B Ratio1.35
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.6 -1.5
P/B 1.4 1.6
ROE % -85.2 -53.4
Net Margin % -5863.5 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
1.47% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0.02% weight
AVES logo AVES Avantis Emerging Markets Value ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) 0.00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 72,102.0 Net Income (TTM) -4.23 M
ROE -85.18% ROA -64.86%
Gross Margin 38.57% Operating Margin -5936.95%
Net Margin -5863.50% Free Cash Flow (TTM) -4.66 M
ROIC -59.97% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8.70
Interest Coverage -114.76 Asset Turnover 0.01
Working Capital 5.46 M Tangible Book Value 4.79 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.60 Forward P/E N/A
P/B Ratio 1.35 P/S Ratio 93.83
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -68.90%
Market Cap 6.77 M Enterprise Value 2.85 M
Per Share
EPS (Diluted TTM) -0.50 Revenue / Share 0.00
FCF / Share -0.29 OCF / Share -0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 110.26%
SBC-Adj. FCF -4.89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72,102.0 72,102.0 72,102.0 — —
Net Income -4.23 M -4.39 M -3.70 M -3.91 M 3.90 M
EPS (Diluted) -0.50 -1.19 — — 0.04
Gross Profit 27,807.0 66,264.0 66,264.0 66,264.0 66,260.0
Operating Income -4.28 M -4.71 M -3.86 M -3.63 M -2.74 M
EBITDA — — — — —
R&D Expenses 2.16 M 2.37 M 845,092.0 1.29 M 693,910.0
SG&A Expenses — — 390,071.0 227,259.0 162,953.0
D&A — — — — —
Interest Expense 37,302.0 5,084.0 4,869.0 2,199.0 54.0
Income Tax — — — 24,876.0 24,876.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7.61 M 7.41 M 7.75 M 11.64 M 10.49 M
Total Liabilities 1.30 M 2.38 M 1.57 M 1.30 M 1.43 M
Shareholders' Equity 6.31 M 5.03 M 6.18 M 10.34 M 9.06 M
Total Debt — — — — —
Cash & Equivalents 4.75 M 3.91 M 3.52 M 11.37 M 9.84 M
Current Assets 7.39 M 7.11 M 7.68 M 11.57 M 10.40 M
Current Liabilities 650,183.0 1.66 M 775,590.0 436,318.0 490,039.0